A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
Prednisone was granted FDA approval on 21 February 1955.
Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
M D Anderson Cancer Center, Houston, Texas, United States
M D Anderson Cancer Center, Houston, Texas, United States
Northwestern University, Chicago, Illinois, United States
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
M D Anderson Cancer Center, Houston, Texas, United States
Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center, Milford, Massachusetts, United States
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, South Weymouth, Massachusetts, United States
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada
University of Rochester, Rochester, New York, United States
Maine Children's Cancer Program, Scarborough, Maine, United States
St. Jude Affiliate Baton Rouge Clinic (Our Lady of the Lakes Regional Medical Center), Baton Rouge, Louisiana, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Pharmaceutical Research Associates, Inc.,, Lenexa, Kansas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.